Home › Funds › Schrum Private Wealth Management LLC › ABT

Schrum Private Wealth Management LLC position in ABT

ABBOTT LABORATORIES · Health Care

Schrum Private Wealth Management LLC reported holding 8,566 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$847K, representing 0.70% of its reported portfolio and ranking #41 among its reported holdings. Schrum Private Wealth Management LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.57K sh
Reported value held$846.56K
Portfolio Weight0.70%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Schrum Private Wealth Management LLC's ABT position evolved

Schrum Private Wealth Management LLC first disclosed a stake in ABT in Q3 2023 at 11,855 shares (US$1.1M). The position peaked in Q3 2024 at 16,610 shares, worth US$1.9M. Across 13 filings, Schrum Private Wealth Management LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 8,566 shares valued at US$847K — a reduction of -419 shares quarter over quarter.. Notable position changes include a 35% trim in Q4 2023 (shares rose 4% over the following quarter), a 54% increase in Q1 2024 (shares fell 8% over the following quarter), a 42% increase in Q3 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.86K $1.15M New
Q4 2023 7.65K $842.42K Reduce
Q1 2024 11.81K $1.34M Add
Q2 2024 11.71K $1.22M Reduce
Q3 2024 16.61K $1.89M Add
Q4 2024 11.29K $1.28M Reduce
Q1 2025 11.29K $1.50M Hold
Q2 2025 11.29K $1.54M Hold
Q3 2025 11.22K $1.50M Reduce
Q4 2025 11.14K $1.40M Reduce
Q1 2026 11.14K $1.14M Hold
Q2 2026 8.98K $924.72K Reduce
Q3 2026 8.57K $846.56K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Schrum Private Wealth Management LLC held ABT?

Schrum Private Wealth Management LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Schrum Private Wealth Management LLC's current position in ABT?

As of Q3 2026, Schrum Private Wealth Management LLC holds 8.57K shares of ABT (ABBOTT LABORATORIES), valued at $846.56K, representing 0.70% of its reported portfolio and ranking #41.

Has Schrum Private Wealth Management LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Schrum Private Wealth Management LLC reduced its position in ABT. The position peaked in Q3 2024 at 16.61K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.